The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

Clinical Tools and Resources for Breast Cancer



The purpose of these clinical tools and resources is to more widely disseminate, in a practical and user-friendly form, the recommendations contained in the guidelines.  In the breast cancer area, ASCO currently has derivative products for four guidelines.

Clinical Tools and Tables

Bone-Modifying Agents in Metastatic Breast Cancer Update Table

Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer Decision Aid Tool

Immunohistochemical Testing of Estrogen/Progesterone Receptors in Breast Cancer Reporting Elements

Breast Cancer Risk Reduction Discussion Guide

Breast Cancer Tumor Markers Matrix

Breast Cancer Markers by Tumor Type Table

Breast Cancer Tumor Markers 2007 Revisions Table

HER-2 Reporting Elements Index

Breast Cancer Surveillance Flow Sheet (.xls)

Breast Cancer Surveillance Flow Sheet (pdf)

Breast Cancer Surveillance 2006 Revisions Table


Journal of Oncology Practice (JOP) Guideline Articles

Bone-Modifying Agents in Metastatic Breast Cancer JOP Summary

Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer JOP Summary

Immunohistochemical Testing of Estrogen/Progesterone Receptors in Breast Cancer JOP Summary

Breast Cancer Risk Reduction JOP Guideline Summary

Breast Cancer Tumor Markers JOP Guideline Summary

HER-2 Testing JOP Guideline Summary

Breast Cancer Surveillance JOP Guideline Summary

Sentinel Node Biopsy JOP Guideline Summary


Summary Slide Sets

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer Slide Set (pps)

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer Slide Set (pdf)

Bone-Modifying Agents in Metastatic Breast Cancer Slide Set (pps)

Bone-Modifying Agents in Metastatic Breast Cancer Slide Set (pdf)

Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer Slide Set (pps)

Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer Slide Set (pdf)

Immunohistochemical Testing of Estrogen/Progesterone Receptors in Breast Cancer Slide Set (pps)

Immunohistochemical Testing of Estrogen/Progesterone Receptors in Breast Cancer Slide Set (pdf)

Breast Cancer Risk Reduction Slide Set (pps)

Breast Cancer Risk Reduction Slide Set (pdf)

Breast Cancer Tumor Markers Slide Set (ppt)

Breast Cancer Tumor Markers Slide Set (pdf)

HER-2 Testing in Breast Cancer Slide Set (ppt)

HER-2 Testing in Breast Cancer Slide Set (pdf)

Breast Cancer Surveillance Slide Set (ppt)

Breast Cancer Surveillance Slide Set (pdf)

Sentinel Node Biopsy in Breast Cancer Slide Set (ppt)

Sentinel Node Biopsy in Breast Cancer Slide Set (pdf)

Patient Guides

Bone-Modifying Agents in Metastatic Breast Cancer Patient Guide

Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer Patient Guide

Immunohistochemical Testing of Estrogen/Progesterone Receptors in Breast Cancer Patient Guide

Breast Cancer Risk Reduction Patient Guide

Breast Cancer Tumor Markers Patient Guide

HER-2 Testing Patient Guide

Breast Cancer Surveillance Patient Guide

Sentinel Node Biopsy Patient Guide


The practice guideline is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients and may not reflect the most recent evidence. The guideline does not recommend any particular product or course of medical treatment. Use of the practice guideline and summary is voluntary. The full practice guideline and additional information are available at http://www.asco.org/guidelines.


Last Updated on 9/6/11


 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005–2012 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.
Feedback Form